Guidelines and indications for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association task force on assessment of diagnostic and therapeutic cardiovascular procedures (subcommittee on coronary artery bypass graft surgery)

Journal of the American College of Cardiology

Volumn 17, Issue 3, 1991, Pages 543-589

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85025492781     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(10)80169-X     Document Type: Note

References (136)

1. Aortocoronary bypass with saphenous vein graft: seven-year follow-up
2. Saphenous vein graft in the surgical treatment of coronary artery disease: operative technique
3. Cardiovascular Diseases. Guidelines for Prevention and Care
4. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events
5. Internal mammary artery: methods of use and their effect on survival
6. Summary of a consensus concerning death and ischemic events after coronary artery bypass grafting
7. Free (aorta-coronary) internal mammary artery graft. Late results
8. Factors influencing long-term (10-year to 15-year) survival after a successful coronary artery bypass operation
9. Risks of bilateral internal mammary artery bypass grafting
10. Internal mammary artery grafts: technical factors influencing patency
11. Event-free survival following non-emergency myocardial revascularization during hypothermic fibrillatory arrest
12. The first American clinical trial of nifedipine in cardioplegia
13. Cardioprotective effects of lidoflazine in extensive aorta-coronary bypass grafting
14. Selective hypothermia of the heart in anoxic cardiac arrest
15. Functional, metabolic, and morphologic effects of potassium-induced cardioplegia
16. Myocardial protection with cold, ischemic potassium-induced cardioplegia
17. Reducing postishemic damage by temporary modification of reperfusate calcium, potassium, pH, and osmolality
18. Coronary and systemic vascular resistance during reperfusion after global myocardial ischemia
19. Benefits of normothermic induction of blood cardioplegia in energy-depleted hearts with maintenance of arrest by multidose cold blood cardioplegic infusions
20. Studies on prolonged acute regional ischemia. VI. Myocardial infarction with left ventricular power failure: a medical/surgical emergency requiring urgent revascularization with maximal protection of remote muscle
21. Nonparametric estimation from incomplete observations
22. Regression models and life tables
23. Covariance analysis of censored survival data
24. The decomposition of timevarying hazard into phases, each incorporating a separate stream of concomitant information
25. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study
26. Coronary Artery Surgery Study (CASS): a randomized trial of coronary bypass surgery. Eight years follow-up survival in patients with reduced ejection fraction
27. Ten-year followup of survival and myocardial infarction in the randomized Coronary Artery Surgery Study (CASS)
28. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina
29. Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Cooperative Study of surgery for coronary arterial occlusive disease
30. Veterans Administration cooperative Study for treatment of patients with unstable angina. Results in patients with abnormal left ventricular function
31. Medical compared with surgical management of unstable angina. 5-year mortality and morbidity in the Veterans Administration study
32. Medical versus early surgical therapy in patients with triple-vessel disease and mild angina pectoris: a CASS registry study of survival
33. Improved survival of surgically treated patients with triple vessel coronary artery disease and severe angina pectoris. A report from the Coronary Artery Surgery Study (CASS) Registry
34. The plights of the invasive treatment of ischemic heart disease
35. A 15-year perspective
36. Detrimental effect of perioperative myocardial infarction on late survival after coronary artery bypass. Report from the Coronary Artery Surgery Study-CASS
37. Use of survival analysis to determine the clinical significance of new Q waves after coronary bypass surgery
38. The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study
39. Quality of life after bypass surgery for unstable angina: 5-year followup results of a Veterans Administration Cooperative Study
40. Coronary Artery Surgery Study (CASS): A randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups'
41. Changes in working status of patients following coronary bypass surgery
42. Retention or resumption of employment after aortocoronary bypass operations
43. Strategies for improving the work status of patients after coronary artery bypass surgery
44. Employment status after coronary artery bypass surgery
45. Survival, myocardial infarction, and employment status in a prospective randomized study of coronary bypass surgery
46. Ten year follow-up of quality of life in patients randomized to medicine versus coronary bypass graft surgery: The Coronary Artery Surgery Study (CASS)
47. study participants: The 5 year effect of bypass surgery on relief of angina and exercise performance
48. Cerebrovascular disease and functional outcome after coronary artery bypass surgery
49. ‘Head and heart’-neurological and psychological reactions to open heart surgery
50. Neurobehavioral outcomes in cardiac operations. A prospective controlled study
51. Neurological complications of coronary artery bypass graft surgery: six month follow-up study
52. Primary myocardial revascularization. Trends in surgical mortality
53. Stroke following coronary artery bypass grafting: a ten-year study
54. Morphology of saphenous vein-coronary artery bypass grafts: 7-116 months postoperative
55. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation
56. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences
57. Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation
58. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery
59. The fate of arm veins used for aorta-coronary bypass grafts
60. Reoperation for coronary atherosclerosis: changing practice in 2509 consecutive patients
61. Intent-to-treat analysis and the problem of crossovers: an example from the VA coronary bypass surgery study
62. Comparison of coronary artery bypass surgery and medical therapy in patients 65 years of age or older
63. Coronary artery bypass graft surgery in the elderly. Indications and outcome
64. Morbidity and mortality of coronary bypass grafting in patients 70 years of age and older
65. Ten year survival after coronary artery bypass surgery for angina in patients aged 65 years and older
66. Coronary artery bypass surgery in patients over age 70 years: report from the Milwaukee Cardiovascular Data Registry
67. Favorable results of coronary artery bypass grafting in patients older than 75 years
68. Early and late results of coronary artery bypass after failed angioplasty. Actuarial analysis of late cardiac events and comparison with initially successful angioplasty
69. Comparison of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty as initial treatment strategies
70. Comparison of multivessel coronary angioplasty with surgical revascularization with both internal mammary arteries
71. Coronary angioplasty versus coronary bypass. Three-year follow-up of a matched series of 250 patients
72. Survival following coronary angioplasty in elderly patients. Comparison with bypass surgery (abstr)
73. A comparison of socio-economics and outcome after multivessel coronary angioplasty or bypass surgery (abstr)
74. Efficacy of percutaneous transluminal coronary angioplasty compared with single-vessel bypass
75. Procedural risk and long-term effectiveness of multivessel coronary angioplasty-1980-1989 (abstr)
76. The role of coronary bypass surgery for ‘left main equivalent’ coronary disease: the Coronary Artery Surgery Study Registry
77. A life table and Cox regression analysis of patients with combined proximal left anterior descending and proximal left circumflex coronary artery disease: non-left main equivalent lesions (CASS)
78. Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease
79. Results of coronary artery surgery in patients with poor left ventricular function (CASS)
80. Asymptomatic left main coronary artery disease in the Coronary Artery Surgery Study (CASS) Registry
81. Medical and surgical management of early Q-wave myocardial infarction. I. Effects of surgical reperfusion on survival, recurrent myocardial infarction, sudden death and functional class at 10 or more years of follow-up
82. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial
83. Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock
84. Plaque Assuring—the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina
85. Atherosclerotic plaque rupture and thrombosis. Evolving concepts
86. Platelet hyperreactivity and prognosis in survivors of myocardial infarction
87. Coronary artery bypass grafting in elderly patients: comparative results in a consecutive series of 469 patients older than 75 years
88. Stroke following coronary artery bypass grafting: a ten-year study
89. A platelet-inhibitor drug trial in coronary-artery bypass operations. Benefit of perioperative dipyridamole and aspirin therapy on early post-operative vein graft patency
90. Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease
91. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration cooperative study
92. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects on antiplatelet therapy. Results of a Veterans Administration cooperative study
93. Risk factors related to progressive narrowing in aorto-coronary vein grafts studied one and five years after surgery
94. Saphenous vein graft patency after 2 years is related to preoperative serum cholesterol and triglyceride levels (abstr)
95. Clinical outcome ten years after coronary bypass: effects of cholesterol and triglycerides in 4,913 patients (abstr)
96. Late thrombosis of saphenous vein coronary bypass grafts related to risk factors
97. Beneficial effects of combined Colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts
98. Aorta-coronary artery saphenous vein bypass surgery. Clinical and angiographic results
99. Guidelines for Exercise Testing: A report of the ACC/AHA Task Force on Assessment of Cardiovascular Procedure
100. Accuracy of treadmill testing in assessment of direct myocardial revascularization
101. Subcommittee on Cardiac Surgery Standards of the Cardiovascular Committee and the Advisory Council for Cardiothoracic Surgery of the American College of Surgeons. Guidelines for minimal standards in cardiac surgery
102. Cardiovascular perfusion: evolution to allied health profession and status 1986
103. Optimal resources for examination of the heart and lungs: cardiac catheterization and radiographic facilities
104. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty)
105. A strategy for cost containment in coronary surgery
106. Rapid sustained recovery after open heart operations
107. Cardiac catheterization and cardiac surgical facilities, use, trends, future requirements
108. Toward optimal utilization of cardiac resources
109. Association of volume with outcome of coronary artery bypass surgery
110. Cardiac surgery in a small community: an eight-year experience
111. Coronary artery bypass surgery. A community hospital's experience
112. Coronary artery bypass grafting. Early and late results in an Alabama community hospital
113. Should operations be regionalized? The empirical relation between surgical volume and mortality
114. Investigation of the relationship between volume and mortality for surgical procedures performed in New York State hospitals
115. Market and regulatory influences on the availability of coronary angioplasty and bypass surgery in U.S. hospitals
116. Cost effectiveness of regionalization: the heart surgery example
117. Planning of specialized health facilities: size versus cost and effectiveness in cardiac surgery
118. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease
119. Coronary artery bypass graft surgery. Assuring quality while controlling Medicare costs
120. Statistical Bulletin
121. Determinants of hospital charges for coronary artery bypass surgery: the economic consequences of postoperative complications
122. Determinants of prolonged length of hospital stay after coronary bypass surgery
123. Grading of angina pectoris
124. Preinfarctional (unstable) angina—a prospective study. Ten year follow-up. Prognostic significance of electrocardiographic changes
125. Unstable angina pectoris: National Cooperative Study Group to Compare Medical and Surgical Therapy. IV. Results in patients with left anterior descending coronary artery disease
126. Unstable angina. A classification
127. Guidelines for coronary angiography. A report of the ACC/AHA Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures
128. Guidelines for percutaneous transluminal coronary angioplasty. A report of the ACC/AHA Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures
129. Determinants of early versus late cardiac death in patients undergoing coronary artery bypass (CAB) (absti)